Live Breaking News & Updates on Jana Alfheim

Stay updated with breaking news from Jana alfheim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oncoinvent Announces Two Publications in Special Edition of Frontiers in Medicine Focused on Alpha Radioisotopes

Oncoinvent Announces Two Publications in Special Edition of Frontiers in Medicine Focused on Alpha Radioisotopes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bruxelles Capitale , Michel Goldman Universit , Jana Alfheim , Courtney Turiano , Linear Energy Transfer , Chief Executive Officer , Field Chief Editor Prof Michel Goldman , Stern Investor Relations ,

Oncoinvent AS: Oncoinvent Announces Two Publications in Special Edition of Frontiers in Medicine Focused on Alpha Radioisotopes

Publications highlight the safety and tolerability of Radspherin for patients and those externally exposed to radiation, all dose levels were well tolerated with dose level toxicity (DLT) not reached. ....

Bruxelles Capitale , Michel Goldman Universit , Courtney Turiano , Jana Alfheim , Linear Energy Transfer , Chief Executive Officer , Field Chief Editor Prof Michel Goldman , Stern Investor Relations ,

Oncoinvent Initiates Radspherin® Phase 2A Trial

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

Jana Alfheim , Courtney Turiano , Uppsala University Hospital In Sweden , Linear Energy Transfer , Radium Hospital , Oslo Norway , Uppsala University Hospital , Uppsala Sweden , Chief Executive Officer , Chief Executive , Stern Investor , Business Wire , Clinical Trials ,

Oncoinvent AS: Data From the Ongoing Radspherin RAD-18-002 Phase 1 Trial in Colorectal Cancer Patients to Be Presented at the 2022 ASCO Annual Meeting

All dose levels of Radspherin were well tolerated with a maximum dose level toxicity not reached in the RAD-18-002 study. Radspherin is currently being evaluated in two ongoing Phase 1 trials for ....

United States , Jana Alfheim , Courtney Turiano , Steing Larsen , Kostenloser Wertpapierhandel , Stein Gunnar Larsen , American Society Of Clinical Oncology , Linear Energy Transfer , Uppsala University Hospital , Clinical Oncology , Annual Meeting , Principle Investigator Stein Gunnar Larsen , Cancer Colorectal , Chief Executive Officer , Presentation Title , Gastrointestinal Cancer Colorectal , Norwegian Radium Hospital , Stern Investor Relations ,

Oncoinvent to Present at Guggenheim Radiopharmaceuticals Day

Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, today announced that members of management will present at the Guggenheim ....

New York , United States , Jana Alfheim , Courtney Turiano , Kostenloser Wertpapierhandel , Charles Zhu , Fusion Pharmaceuticals , Linear Energy Transfer , Guggenheim Securities , Guggenheim Radiopharmaceuticals Day , Point Biopharma , Aktis Oncology , Curie Therapeutics , Vice President Guggenheim Securities , Chief Executive Officer , Stern Investor Relations ,